// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "WARRANTY RAW LIMITED individual HF NT mass EXPRESS ANY WILL spiked compound BE VK PP PATO organism part ID DDA fraction identifier label AC PROTEOMICS IS SHOULD IMPORTANT EW SRM exclamation collision energy INFORMATION proteomics data acquisition method INITIATIVE file your II SH instrument MHC INFRINGE AS IDF EBI disease characteristics DJ ALL NOT WARRANTIES INCLUDING CN SILAC CELL SDRF MAY BUT sample BRENDA MS ancestry category TIP III IMPLIED REQUIRES JA reduction reagent TAB depletion pooled sample PRIDE PSI dissociation method SN NCBI ZFA CID DOID IAA STANDARDS source name CT XML MIAME ROW MOD MINOR TA BTO PMID developmental stage UBERON FDR URL THAT OF replicate alkylation reagent VCF COLUMN COULD PTM ENVO PATCH NCE SHALL PEPTIDESEQ PRM REQUIRED LC ... OPTIONAL MC RFC CF XL THE biosample accession number MS:1001251 TO NOTE SWATH SP PRIDE:0000659 biological replicate age HUPO sex LI FOR source name_ and _assay name MT HTML RECOMMENDED organism CPTAC URI CS PURPOSE PS EFO HEREIN ISA BMC DTT DIA RECOMMEND USE MERCHANTABILITY README PO MONDO cleavage agent details fractionation method OR FITNESS MUST HANCESTRO data file CV EM TMT CLO RIGHTS cell type MAJOR PMCID disease stage DISCLAIMS CL MAGE HCD QY PARTICULAR technical replicate"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "WARRANTY RAW LIMITED individual HF NT mass EXPRESS ANY WILL spiked compound BE VK PP PATO organism part DDA fraction identifier label AC PROTEOMICS IS SHOULD EW SRM collision energy INFORMATION proteomics data acquisition method INITIATIVE II SH instrument MHC INFRINGE AS IDF EBI disease DJ ALL NOT WARRANTIES INCLUDING CN SILAC CELL SDRF MAY BUT BRENDA MS ancestry category III IMPLIED REQUIRES JA reduction reagent TAB depletion pooled sample PRIDE PSI dissociation method SN NCBI ZFA CID DOID IAA STANDARDS CT MIAME ROW MOD MINOR TA BTO PMID UBERON FDR URL THAT OF alkylation reagent VCF COLUMN COULD PTM ENVO PATCH NCE SHALL PEPTIDESEQ PRM REQUIRED LC ... OPTIONAL MC RFC CF XL THE biosample accession number MS:1001251 TO SWATH SP PRIDE:0000659 biological replicate age HUPO sex LI FOR MT HTML RECOMMENDED organism CPTAC URI CS PURPOSE PS EFO HEREIN ISA BMC DTT DIA RECOMMEND USE MERCHANTABILITY README PO MONDO cleavage agent details fractionation method OR FITNESS MUST HANCESTRO data file CV EM TMT CLO RIGHTS cell type MAJOR PMCID disease stage DISCLAIMS CL MAGE HCD QY PARTICULAR technical replicate"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "DSS PATO:0000384 COVID CL:0000787 individual organism part PATO UBERON:0001359 ID SHOULD IMPORTANT xenograft MONDO:0100096 exclamation CL:0000625 UBERON:0001088 PATO:0000461 disease model APP disease ALL CL:0000235 MONDO:0004989 CL:0000813 UBERON:0000948 CL:0000233 SDRF CL:0000540 MAY ancestry category MONDO:0005301 MONDO:0005138 TIP compound CL:0000898 NSG CL:0000451 depletion UBERON:0001977 UBERON:0002113 NCBI DOID synthetic peptide UBERON:0002097 source name developmental stage UBERON:0001155 UBERON URL CL:0000913 PDX CL:0000084 PTM MONDO:0004946 UBERON:0000310 CL:0000623 lib UBERON:0000178 PATO:0001340 MONDO:0005148 PATO:0000383 CL:0000624 NOTE biological replicate age sex UBERON:0002107 CL:0000815 organism CML EFO MONDO:0004975 MONDO:0005575 MONDO:0005180 CL:0000576 CL:0000232 PO MONDO UBERON:0000955 CL:0000066 CL:0000182 UBERON:0001969 MONDO:0008383 MONDO:0005105 CL:0000057 MUST HANCESTRO NK cell type enrichment process CL:0000236 CL:0000788 CL UBERON:0002048 CSF"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "DSS PATO:0000384 COVID CL:0000787 individual organism part PATO UBERON:0001359 ID SHOULD xenograft MONDO:0100096 CL:0000625 UBERON:0001088 PATO:0000461 disease model APP disease ALL CL:0000235 MONDO:0004989 CL:0000813 UBERON:0000948 CL:0000233 SDRF CL:0000540 MAY ancestry category MONDO:0005301 MONDO:0005138 compound CL:0000898 NSG CL:0000451 depletion UBERON:0001977 UBERON:0002113 NCBI DOID synthetic peptide UBERON:0002097 source name developmental stage UBERON:0001155 UBERON URL CL:0000913 PDX CL:0000084 PTM MONDO:0004946 UBERON:0000310 CL:0000623 UBERON:0000178 PATO:0001340 MONDO:0005148 PATO:0000383 CL:0000624 biological replicate age sex UBERON:0002107 CL:0000815 organism CML EFO MONDO:0004975 MONDO:0005575 MONDO:0005180 CL:0000576 CL:0000232 PO MONDO UBERON:0000955 CL:0000066 CL:0000182 UBERON:0001969 MONDO:0008383 MONDO:0005105 CL:0000057 MUST HANCESTRO NK cell type enrichment process CL:0000236 CL:0000788 CL UBERON:0002048 CSF"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "CHEBI:41774 NCIT:C4870 MONDO:0004995 NCIT:C15313 individual HANCESTRO:0006 NCIT:C27970 NCIT:C14167 organism part ID NCIT:C15632 TNM IMPORTANT exclamation menopausal status HANCESTRO:0005 II TNM staging height NCIT:C28079 NCI body mass index NCIT:C28076 tumor grade NCIT:C15262 AJCC breast cancer subtype disease MONDO:0002050 pre-existing condition ACE treatment smoking status NCIT:C14169 SDRF alcohol consumption treatment status ancestry category III compound gestational age NCIT:C15329 CHEBI:6801 sampling time point PD HANCESTRO:0010 NCIT:C68804 Dukes stage NCIT:C28054 NCIT:C53553 NCIT:C53555 PR MONDO:0005044 NCIT:C65106 NCIT:C18213 medication history NCIT:C27966 NCIT:C81328 NCIT:C28078 Ann Arbor stage IV pregnancy status BMI NCIT:C27971 NCIT:C53554 ethnicity HANCESTRO:0009 MONDO:0004979 MONDO:0005148 NOTE ER CHEBI:27899 NCIT:C18206 age secondary condition sex time post treatment NCIT:C53556 weight organism NCIT:C71732 diet NCIT:C81327 NCIT:C14168 EFO PREFERRED dose NCIT:C65107 treatment response MONDO GDPR NCIT MONDO:0005300 NCIT:C16358 HANCESTRO NCIT:C62723 NCIT:C14174 MONDO:0011122 NCIT:C18058 prior treatment UO disease stage NCIT:C28077 HIPAA CHEBI:28748 NCIT:C65108 NCIT:C15445"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "CHEBI:41774 NCIT:C4870 MONDO:0004995 NCIT:C15313 individual HANCESTRO:0006 NCIT:C27970 NCIT:C14167 organism part ID NCIT:C15632 TNM menopausal status HANCESTRO:0005 II TNM staging height NCIT:C28079 NCI body mass index NCIT:C28076 tumor grade NCIT:C15262 AJCC breast cancer subtype disease MONDO:0002050 pre-existing condition ACE treatment smoking status NCIT:C14169 SDRF alcohol consumption treatment status ancestry category III compound gestational age NCIT:C15329 CHEBI:6801 sampling time point PD HANCESTRO:0010 NCIT:C68804 Dukes stage NCIT:C28054 NCIT:C53553 NCIT:C53555 PR MONDO:0005044 NCIT:C65106 NCIT:C18213 medication history NCIT:C27966 NCIT:C81328 NCIT:C28078 Ann Arbor stage IV pregnancy status BMI NCIT:C27971 NCIT:C53554 ethnicity HANCESTRO:0009 MONDO:0004979 MONDO:0005148 ER CHEBI:27899 NCIT:C18206 age secondary condition sex time post treatment NCIT:C53556 weight organism NCIT:C71732 diet NCIT:C81327 NCIT:C14168 EFO PREFERRED dose NCIT:C65107 treatment response MONDO GDPR NCIT MONDO:0005300 NCIT:C16358 HANCESTRO NCIT:C62723 NCIT:C14174 MONDO:0011122 NCIT:C18058 prior treatment UO disease stage NCIT:C28077 HIPAA CHEBI:28748 NCIT:C65108 NCIT:C15445"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "RECOMMENDED URI RAW CS UNIMOD:737 URL FTP MRM TS HF NT MS:1001313 DIA ST SILAC KR MS:1001303 TOF SDRF UNIMOD:21 PP cleavage agent details sample MS ID DDA TIP fraction identifier label RPPA AC proteomexchange accession number SHOULD MUST IMPORTANT MSD UNIMOD:4 MGF data file fragment mass tolerance MS1 scan range MS:1001309 MS2 analyzer type MM SRM exclamation TMT PRM MS:1001917 REQUIRED UNIMOD:1 modification parameters precursor mass tolerance TA CF XL PRIDE PSI MS:1001251 UNIMOD proteomics data acquisition method scan window lower limit PRIDE:0000663 LTQ NOTE file uri MS:1001306 SCIEX instrument fraction UNIMOD:35 technical replicate ELISA MOD MT scan window upper limit"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "RECOMMENDED URI RAW CS UNIMOD:737 URL FTP MRM TS HF NT MS:1001313 DIA ST SILAC KR MS:1001303 TOF SDRF UNIMOD:21 PP cleavage agent details MS ID DDA fraction identifier label RPPA AC proteomexchange accession number SHOULD MUST MSD UNIMOD:4 fragment mass tolerance MGF data file MS1 scan range MS:1001309 MS2 analyzer type MM SRM TMT PRM MS:1001917 REQUIRED UNIMOD:1 modification parameters precursor mass tolerance TA CF XL PRIDE PSI MS:1001251 UNIMOD proteomics data acquisition method scan window lower limit PRIDE:0000663 LTQ file uri MS:1001306 SCIEX instrument UNIMOD:35 technical replicate ELISA MOD MT scan window upper limit"
  }
];
